Tech Guruji's video: Anti-Covid drug 2-DG 2-DG

Hey dosto, The first batch of 2-deoxy-D-glucose (2-DG) drug for the treatment of moderate to severe Covid-19 cases will be launched next week, the Defence Research and Development Organisation has said. "The first batch of 10,000 doses of 2-DG medicine for the treatment of Covid-19 infected patients would be launched early next week and will be given to patients," "The drug manufacturers are working on ramping up the production of the medicine for future use. The drug has been developed by a team of DRDO scientists including Dr Anant Narayan Bhatt," the official added. How was 2-DG developed? How were clinical trials conducted? DRDO Project Director and Scientist of 2-DG, Dr Sudhir Chandana has said that when the pandemic hit India in April 2020, they discovered that 2-DG halts the spread of COVID-19 inside the body cells. "After the findings, we asked the DCGI for permission to conduct clinical trials," he said. In May 2020, the DRDO received permission to conduct the clinical trials. The phase 2 trials were concluded in October 2020. The results showed that in terms of improvement of vital signs of COVID-19 symptomatic patients, there was a difference of 2.5 days compared to Standard of Care (SoC). Approval for Phase - III clinical trials were granted in November 2020. These were conducted in 27 COVID-19 hospitals spread across several states. "Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence," an official DRDO statement had explained earlier. Note : This vdo is only for information.